<DOC>
	<DOC>NCT01606033</DOC>
	<brief_summary>This study aims to assess anxiety/depression and life quality of patients included in clinical trials versus patients treated in a standard way.</brief_summary>
	<brief_title>Study of Stress and Life Quality of Patients Participating in Clinical Trials Versus Patients Non Participating</brief_title>
	<detailed_description>This study aims to assess anxiety/depression and life quality of patients included in clinical trials versus patients treated in a standard way A case-control study</detailed_description>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>patient with solid tumor or recurrent hematologic cancer, treated by chemotherapy or targeted therapy evaluated every 2 or 3 cycles; except for clinical trials associating non drug treatment (radiotherapy, surgery...) subject to a 1st, 2nd or 3rd line of antitumor treatment a phase 2 open labeled study, a phase 2 or 3 blind randomised study, a phase 2 or 3 open randomised study, a standard treatment non participating to a clinical trial male or female patients ≥ 18 years of age karnovsky ≥ 70 % or OMS ≤ 2 recovered from prior toxicities social security covered written informed consent given psychiatric disorders, receiving psychotropic treatment physical or psychological issues forbidden to be included in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stress</keyword>
	<keyword>Life quality</keyword>
	<keyword>adjustment strategy</keyword>
	<keyword>receiving an antitumor treatment</keyword>
	<keyword>within a clinical trial (case)</keyword>
	<keyword>according to a standard treatment (control)</keyword>
</DOC>